QantX
  • Home
  • Invest
  • Team
  • Strategy
  • Portfolio
  • News
  • Contact
  • Investor Portal
Select Page

Don’t invest unless you’re prepared to lose all the money you invest. This is a high‑risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more. 

News

Follow us on LinkedIn
SENISCA secures additional £3.7 million financing to support rapid development of senotherapeutic platform to treat age-related disease

SENISCA secures additional £3.7 million financing to support rapid development of senotherapeutic platform to treat age-related disease

by Harry | Mar 27, 2024 | Portfolio

The SETsquared partnership named by FT and Sifted in top 3 startup hubs of Europe

The SETsquared partnership named by FT and Sifted in top 3 startup hubs of Europe

by Harry | Mar 14, 2024 | Uncategorized

Beyond the Golden Triangle

Beyond the Golden Triangle

by Harry | Sep 12, 2023 | Climate, Healthcare, Innovation

QantX Announces Three New Awardees of the Blavatnik Prize for Innovation 

QantX Announces Three New Awardees of the Blavatnik Prize for Innovation 

by Harry Alexander | Apr 26, 2023 | Innovation Prize

iFAST Diagnostics raise £2M to track and treat antibiotic-resistant bugs

iFAST Diagnostics raise £2M to track and treat antibiotic-resistant bugs

by Harry Alexander | Feb 16, 2023 | Healthcare, Portfolio

Molendotech secures investment from QantX

Molendotech secures investment from QantX

by Harry Alexander | Jan 9, 2023 | Healthcare

Blavatnik Prize for Innovation supports Lutra Health

Blavatnik Prize for Innovation supports Lutra Health

by Harry Alexander | Nov 8, 2022 | Healthcare, Innovation Prize

Molydyn wins a Blavatnik Prize for Innovation

Molydyn wins a Blavatnik Prize for Innovation

by Harry Alexander | Oct 31, 2022 | Innovation, Innovation Prize

QantX invests in Watercress Research

QantX invests in Watercress Research

by Harry Alexander | Oct 24, 2022 | Healthcare, Portfolio

SensefulAI awarded a Blavatnik Prize for Innovation

SensefulAI awarded a Blavatnik Prize for Innovation

by Harry Alexander | Oct 6, 2022 | Innovation, Innovation Prize

Next Entries »

enquiries@qantx.co.uk

Contact Us
Apply for Funding

This website is a financial promotion for the purposes of Section 21 of FSMA. It is issued by QantX Ltd (FRN: 954072), an Appointed Representative of Kin Capital Partners LLP FRN:656789, an AIFM as defined by the AIFMD, who have approved it, on 31/01/24, and who are authorised by the FCA.

This website is not an offer to buy or sell securities and does not constitute a Direct Offer Financial Promotion. Applications for investment may only be made on the basis of the relevant documentation, copies of which are available on request. No reliance is to be placed on the information contained in this website in making such an application. Information herein is not intended to, nor should be taken to, constitute advice. This material is directed only at persons in the UK.


© 2022 QantX. All rights reserved. Cookie Policy | Privacy Policy | Risk Statement
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy